MabGenesis, Inc. operates as a biopharmaceutical company that develops therapeutic monoclonal antibody drugs in the human and animal fields. It develops antibody libraries as MOURA Libraries in terms of functionality and completeness, and highly efficient monoclonal antibody isolation technology. The company was founded on June. 3, 2019 and is headquartered in Yokohama, Japan.